Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxytripterin tablet in active rheumatoid arthritis with inadequate methotrexate response
CTR20140491Phase 2Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Jul 2014
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxytriptolide in rheumatoid arthritis (RA), sponsored by Shanghai Institute of Materia Medica. Started Jul 2014; status: completed.
02
Drugs
hydroxytriptolide
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on CTR20140491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140491.